Category: Joint ventures/collaborations
-
Trial to Test Mobile App for Kidney Disease Screening
A clinical trial will soon get under way that tests whether a smartphone app can easily and accurately screen for chronic kidney disease among people with high blood pressure.
-
Advanced Wireless Research Platforms in Development
Test networks for advanced research on wireless technology are being established in Utah and New York by an academic-industry consortium coordinated by National Science Foundation.
-
Lilly, Cell Implants Start-Up Partner on Diabetes
Eli Lilly and Company is licensing a technology for implanting pancreatic beta cells in people with type 1 diabetes, from Sigilon Therapeutics Inc., an enterprise making implants of live cells to treat chronic diseases.
-
New Company Acquires Off-the-Shelf T-Cell Cancer Therapies
A new enterprise is formed to develop treatments for cancer using donated T-cells from the immune system, rather than the patient’s own T-cells, engineered to attack cancer cells.
-
Crowdsourced Project Building Whole Beta Cell Model
A new initiative is seeking participants from the worldwide research community to develop a multi-dimensional online model of the beta cell that produces insulin, found in the pancreas.
-
Analysis Reveals Ransomware Payment, Support Networks
In a two-year study, engineers and computer scientists trace the networks used by perpetrators to break in, encrypt, and hold for ransom the contents of personal or business computer systems, a growing form of cyber attack.
-
Novartis Licenses Biomaterial for Cancer Immunotherapy
Drug maker Novartis is licensing from a lab at Harvard University a biocompatible material designed to provide delivery of treatments that invoke the immune system to fight cancer.
-
Study Using Phones to Examine Blood Pressure, Stress
A new research project is underway to better understand the linkages between stress and blood pressure, using surveys and physiological data collected with Samsung smartphones.
-
A.I. Shown to Boost Cancer Clinical Trial Enrollment
Early results from a system using a supercomputer and artificial intelligence to match breast cancer patients to clinical trials shows faster screening and higher enrollment rates in these studies compared to manual methods.
-
Company Formed to Develop Cancer Cell Therapies
The MD Anderson Cancer Center in Houston is starting Optera Therapeutics Corp., a new company to commercialize its research on treating cancer with a patients’ own immune system cells.